How a New SCOTUS Ruling Could Affect Pharma ETFs

The VanEck Vectors Generic Drugs ETF (NasdaqGM: GNRX) traded slightly higher Tuesday after the U.S. Supreme Court issued what some industry observers are calling a mixed ruling on expediting the availability of lower-cost equivalents to high-priced biotechnology drugs. “The justices said patent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.